Salvage Systemic Therapy for Advanced Urothelial Carcinoma: On the Cusp of a Sea Change?

Por Sonpavde, Guru, Bellmunt, Joaquim
Publicado no Oncologist (2015)

Circulating Biomarkers in Bladder Cancer

Por Nandagopal, Lakshminarayanan, Sonpavde, Guru
Publicado no Bladder Cancer (2016)

Combination therapy for metastatic renal cell carcinoma

Por Buonerba, Carlo, Di Lorenzo, Giuseppe, Sonpavde, Guru
Publicado no Ann Transl Med (2016)

New advancements and developments in treatment of renal cell carcinoma: focus on pazopanib

Por Cowey, C Lance, Sonpavde, Guru, Hutson, Thomas E
Publicado em 2010

Novel agents for advanced bladder cancer

Por Sonpavde, Guru, Elfiky, Aymen A., Rosenberg, Jonathan E.
Publicado em 2009

Role of Chemotherapy and Mechanisms of Resistance to Chemotherapy in Metastatic Castration-Resistant Prostate Cancer

Por Lohiya, Vipin, Aragon-Ching, Jeanny B., Sonpavde, Guru
Publicado no Clin Med Insights Oncol (2016)

Immunotherapy of advanced renal cell carcinoma: Current and future therapies

Por Gill, David, Hahn, Andrew W., Sonpavde, Guru, Agarwal, Neeraj
Publicado no Hum Vaccin Immunother (2016)

Emerging Vaccine Therapy Approaches for Prostate Cancer

Por Sonpavde, Guru, Slawin, Kevin M, Spencer, David M, Levitt, Jonathan M
Publicado em 2010

Andrographolide inhibits prostate cancer by targeting cell cycle regulators, CXCR3 and CXCR7 chemokine receptors

Por Mir, Hina, Kapur, Neeraj, Singh, Rajesh, Sonpavde, Guru, Lillard, James W., Singh, Shailesh
Publicado no Cell Cycle (2016)

Epigenetics in Prostate Cancer

Por Albany, Costantine, Alva, Ajjai S., Aparicio, Ana M., Singal, Rakesh, Yellapragada, Sarvari, Sonpavde, Guru, Hahn, Noah M.
Publicado em 2011

The Association Between Radiographic Response and Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer Receiving Chemotherapy

Por Sonpavde, Guru, Pond, Gregory R., Berry, William R., de Wit, Ronald, Eisenberger, Mario A., Tannock, Ian F., Armstrong, Andrew J.
Publicado em 2011

Improved 5-factor prognostic classification of patients receiving salvage systemic therapy for advanced urothelial carcinoma

Por Sonpavde, Guru, Pond, Gregory R., Rosenberg, Jonathan E., Bajorin, Dean F., Choueiri, Toni K., Necchi, Andrea, Di Lorenzo, Giuseppe, Bellmunt, Joaquim
Publicado no J Urol (2015)

The activity of the androgen receptor variant AR-V7 is regulated by FOXO1 in a PTEN-PI3K-AKT-dependent way

Por Mediwala, Sanjay N., Sun, Huiying, Szafran, Adam T., Hartig, Sean M., Sonpavde, Guru, Hayes, Teresa G., Thiagarajan, Perumal, Mancini, Michael A., Marcelli, Marco
Publicado em 2012

Metabolic complications with the use of mTOR inhibitors for cancer therapy

Por Sivendran, Shanthi, Agarwal, Neeraj, Gartrell, Benjamin, Ying, Jian, Boucher, Kenneth M., Choueiri, Toni K., Sonpavde, Guru, Oh, William K., Galsky, Matthew D.
Publicado no Cancer Treat Rev (2013)

Pulmonary complications with the use of mTOR inhibitors in targeted cancer therapy: a systematic review and meta-analysis

Por Gartrell, Benjamin A., Ying, Jian, Sivendran, Shanthi, Boucher, Kenneth M., Choueiri, Toni K., Sonpavde, Guru, Oh, William K., Agarwal, Neeraj, Galsky, Matthew D.
Publicado no Target Oncol (2013)

Obesity and Outcomes in Patients with Metastatic Urothelial Carcinoma(1)

Por Leiter, Amanda, Doucette, John, Krege, Susan, Lin, Chia-Chi, Hahn, Noah, Ecke, Thorsten, Sonpavde, Guru, Bamias, Aristotle, Oh, William K., Galsky, Matthew D.
Publicado no Bladder Cancer (2016)

Endostatin inhibits androgen-independent prostate cancer growth by suppressing nuclear receptor-mediated oxidative stress

Por Lee, Joo Hyoung, Kang, Minsung, Wang, Hong, Naik, Gurudatta, Mobley, James A., Sonpavde, Guru, Garvey, W. Timothy, Darley-Usmar, Victor M., Ponnazhagan, Selvarangan
Publicado no FASEB J (2017)

Evaluating the Value of Number of Cycles of Docetaxel and Prednisone in Men With Metastatic Castration-Resistant Prostate Cancer

Por Pond, Gregory R., Armstrong, Andrew J., Wood, Brian A., Brookes, Melissa, Leopold, Lance, Berry, William R., de Wit, Ronald, Eisenberger, Mario A., Tannock, Ian F., Sonpavde, Guru
Publicado em 2011

Third-Line Chemotherapy for Metastatic Urothelial Cancer: A Retrospective Observational Study

Por Di Lorenzo, Giuseppe, Buonerba, Carlo, Bellelli, Teresa, Romano, Concetta, Montanaro, Vittorino, Ferro, Matteo, Benincasa, Alfonso, Ribera, Dario, Lucarelli, Giuseppe, De Cobelli, Ottavio, Sonpavde, Guru, De Placido, Sabino
Publicado no Medicine (Baltimore) (2015)

CD24 Is a Genetic Modifier for Risk and Progression of Prostate Cancer

Por Zhang, Yifan, Li, Bingjin, Zhang, Xingyi, Sonpavde, Guru P., Jiao, Kenneth, Zhang, Andrea, Zhang, Guangxin, Sun, Mei, Chu, Chengjing, Li, Feng, Wang, Lizhong, Cui, Ranji, Liu, Runhua
Publicado no Mol Carcinog (2016)